Abstract |
Treatment of extensively drug-resistant tuberculosis ( XDR-TB) is a challenge. We describe a young child with pulmonary XDR-TB who did not respond to an aggressive multidrug-resistant TB treatment regimen, but was cured with linezolid in combination with other reserve antituberculous drugs. No serious adverse events were observed during 19 months of treatment for XDR-TB.
|
Authors | H Simon Schaaf, Marianne Willemse, Peter R Donald |
Journal | The Pediatric infectious disease journal
(Pediatr Infect Dis J)
Vol. 28
Issue 8
Pg. 748-50
(Aug 2009)
ISSN: 0891-3668 [Print] United States |
PMID | 19633523
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Acetamides
- Antitubercular Agents
- Oxazolidinones
- Linezolid
|
Topics |
- Acetamides
(administration & dosage, adverse effects)
- Antitubercular Agents
(administration & dosage)
- Drug Administration Schedule
- Drug Resistance, Multiple, Bacterial
- Extensively Drug-Resistant Tuberculosis
(drug therapy, microbiology)
- Female
- Humans
- Infant
- Linezolid
- Oxazolidinones
(administration & dosage, adverse effects)
- Tuberculosis, Pulmonary
(drug therapy, microbiology)
|